Preventive MRI Target hospitals and BC clinics with MRI-first breast cancer screening programs, emphasizing the ability to detect dangerous lesions earlier and the potential to reduce costly downstream treatments.

Cryo Immunotherapy Position cryoablation as a preferable preventive approach that may reduce the need for biopsy, surgery, radiation, and chemotherapy, offering a compelling value proposition for payer negotiations and clinical adoption.

Cost Savings Highlight potential U.S. healthcare cost reductions up to ten billion dollars annually by preempting traditional cancer workflows, creating opportunities for value-based procurement discussions.

Affordability & Access Leverage abbreviated MRI protocols and scalable cloud/tech stack to appeal to centers seeking more affordable screening options, unlocking broader adoption and new pilot sites.

Strategic Partnerships Identify collaboration opportunities with larger diagnostic imaging players and oncology platforms to accelerate market entry, leverage existing sales channels, and expand patient reach.